Inventor
BRUCE MARK
US22 patents
⚠️ This page may combine multiple inventors who share the name “BRUCE MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OXFORD NANOPORE TECH LTD
6 patentsUS9777049B2Oct 3, 2017
Mutant lysenin pores
OXFORD NANOPORE TECH LTD36 citations97
US10882889B2Jan 5, 2021
Mutant lysenin pores
OXFORD NANOPORE TECH LTD22 citations94
US9797009B2Oct 24, 2017
Enzyme construct
OXFORD NANOPORE TECH LTD21 citations93
US11180741B2Nov 23, 2021
Modified enzymes
OXFORD NANOPORE TECH LTD10 citations85
US10392658B2Aug 27, 2019
Method for controlling the movement of a polynucleotide through a transmembrane pore
OXFORD NANOPORE TECH LTD14 citations84
US10808231B2Oct 20, 2020
Modified helicases
OXFORD NANOPORE TECH LTD10 citations82
OXFORD NANOPORE TECH PLC
5 patentsUS11845780B2Dec 19, 2023
Mutant lysenin pores
OXFORD NANOPORE TECH PLC7 citations86
US11739377B2Aug 29, 2023
Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
OXFORD NANOPORE TECH PLC10 citations85
US11939359B2Mar 26, 2024
Mutant pore
OXFORD NANOPORE TECH PLC5 citations83
US12258591B2Mar 25, 2025
Modified helicases
OXFORD NANOPORE TECH PLC1 citations74
US11965183B2Apr 23, 2024
Modified enzymes
OXFORD NANOPORE TECH PLC5 citations74
NIKE INC
5 patentsUS12250981B2Mar 18, 2025
Analog control systems and methods for adaptive apparel
NIKE INC1 citations63
US12582174B2Mar 24, 2026
Mechanical control systems and methods for adaptive apparel
NIKE INC0 citations61
US12161171B2Dec 10, 2024
Digital control systems and methods for adaptive apparel
NIKE INC0 citations61
US12059042B2Aug 13, 2024
Mechanical control systems and methods for adaptive apparel
NIKE INC1 citations61
US12137755B2Nov 12, 2024
Adaptive apparel with support control system
NIKE INC0 citations50
GLAXO GROUP LTD
3 patentsUS9750726B2Sep 5, 2017
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
GLAXO GROUP LTD5 citations78
US11090294B2Aug 17, 2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
GLAXO GROUP LTD1 citations67
US12396986B2Aug 26, 2025
Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonist
GLAXO GROUP LTD0 citations57